Articles

The International Comparative Legal Guide to: Pharmaceutical Advertising 2016 – Belgium Chapter

The International Comparative Legal Guide to: Pharmaceutical Advertis

The International Comparative Legal Guide to: Pharmaceutical Advertising 2016 – Belgium Chapter

27.06.2016 BE law

ICLG’s International Comparative Legal Guide to: Pharmaceutical Advertising 2016 provides corporate counsel and international practitioners with a comprehensive worldwide legal analysis of pharmaceutical advertising laws and regulations, including advertisements to healthcare professionals, gifts and financial incentives, and so on.

The guide covers more than 33 jurisdictions, from Australia to the USA.

Manuel Campolini and Olivia Hottat, Brussels intellectual property lawyers, cover the Belgian chapter in this guide. In their contribution, they provide a broad overview of common issues in pharmaceutical advertising laws and regulations in Belgium.

Click on the link below to open a printable version of our contribution. For an online version, please click here.
 

Source: This article appeared in the 2016 edition of The International Comparative Legal Guide to: Pharmaceutical advertising published by Global Legal Group Ltd, London.

Related news

14.10.2021 NL law
NFTs: New legal challenges on the horizon

Short Reads - Non-Fungible Tokens, widely known as NFTs, have recently gained much attention due to their role in the transfer of digital artworks. The market for NFTs grew from USD 13.5m in the first six months of 2020 to USD 2.5bn in the first half of 2021 and is still growing at an expansive rate. Notwithstanding their increasing popularity in the world of art, NFTs have many potential applications. In this blog Maciek Bednarski, Annemijn Witkam and Roderik Vrolijk explain what NFTs are and describe some of the legal challenges they will bring about.

Read more